Latest Content

  • Explore this Interactive Case Challenge in metastatic lung cancer to improve your clinical decisions. The case follows a patient from diagnosis through disease progression of metastatic NSCLC adenocarcinoma that is negative for EGFR mutations and ALK and ROS1 rearrangements, including choice of first-line, maintenance, and second-line treatments.

    Management of a Patient With Metastatic Lung Adenocarcinoma Without Actionable Mutations

    Explore this Interactive Case Challenge in metastatic lung cancer to improve your clinical decisions. The case follows a patient from diagnosis through disease progression of metastatic NSCLC adenocarcinoma that is negative for EGFR mutations and ALK and ROS1 rearrangements, including choice of first-line, maintenance, and second-line treatments.
    Date Posted: 2/9/2016
  • Expert faculty review key data informing the optimal use of contemporary HIV treatment across settings, including first-line treatment, antiretroviral therapy (ART) modification in virologically suppressed patients or those experiencing virologic failure, treatment as prevention, managing ART in the context of common comorbidities, or ART in patients with viral hepatitis coinfection.

    Contemporary Management of HIV

    Expert faculty review key data informing the optimal use of contemporary HIV treatment across settings, including first-line treatment, antiretroviral therapy (ART) modification in virologically suppressed patients or those experiencing virologic failure, treatment as prevention, managing ART in the context of common comorbidities, or ART in patients with viral hepatitis coinfection.
    Date Posted: 2/9/2016
  • This resource guide, downloadable slideset, and webcast are in conjunction with the live workshop series developed by Thomas H. Cartwright, MD, and Herbert Hurwitz, MD, for clinicians who treat patients in the VHA system with pancreatic cancer. Topics include diagnosis and staging; selection and application of optimal therapeutic strategies; and management of AEs in patients with newly diagnosed or relapsed/refractory advanced pancreatic cancer.

    Expert Perspectives: New Opportunities in Advanced Pancreatic Cancer

    This resource guide, downloadable slideset, and webcast are in conjunction with the live workshop series developed by Thomas H. Cartwright, MD, and Herbert Hurwitz, MD, for clinicians who treat patients in the VHA system with pancreatic cancer. Topics include diagnosis and staging; selection and application of optimal therapeutic strategies; and management of AEs in patients with newly diagnosed or relapsed/refractory advanced pancreatic cancer.
    Date Posted: 1/13/2016
  • This CE-certified text module with embedded slides covers data and strategies needed for the optimal nursing management of patients with B-cell malignancies.
To supplement this online activity, there will be a series of <a href='/Oncology/Live Events/Meeting Series/Bcell Malignancies 2016.aspx' target='_blank'>case-based, CE-certified, live meetings</a> to interactively discuss the application of information presented in this module.

    Nursing Viewpoints: Clinical Challenges, Best Practices, and Patient Education Strategies for B-Cell Malignancies

    This CE-certified text module with embedded slides covers data and strategies needed for the optimal nursing management of patients with B-cell malignancies. To supplement this online activity, there will be a series of case-based, CE-certified, live meetings to interactively discuss the application of information presented in this module.
    Date Posted: 1/11/2016
  • In this interactive text module with embedded, downloadable slides, Maria E. Suarez-Almazor, MD, PhD, reviews the management of patients with rheumatoid arthritis who have a current or previous malignancy or are at increased risk for malignancy.

    Managing Rheumatoid Arthritis Post Malignancy: A Case-Based Discussion

    In this interactive text module with embedded, downloadable slides, Maria E. Suarez-Almazor, MD, PhD, reviews the management of patients with rheumatoid arthritis who have a current or previous malignancy or are at increased risk for malignancy.
    Date Posted: 12/18/2015
Decision Support
Free
inPractice
Immediate answers to treatment questions
More than just up to date